Cilostazol Reduces Restenosis Following Endovascular Therapy in Patients with Femoro-popliteal Lesions
Not Applicable
- Conditions
- Patients who underwent endovascular therapy for symptomatic de novo FP lesions
- Registration Number
- JPRN-UMIN000001036
- Lead Sponsor
- Kansai Rosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 127
Inclusion Criteria
Not provided
Exclusion Criteria
acute onset critical limb ischemia, previous bypass surgery or angioplasty for the FP lesions, presence of untreated pelvic lesions, and known intolerance to the medication or contrast agents
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method patency
- Secondary Outcome Measures
Name Time Method 1) Target lesion revascularization 2) All events included restenosis, amputation and death from any causes